Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.
- Author:
Na Hee KIM
1
;
Jee Bum LEE
;
Sook Jung YUN
Author Information
- Publication Type:Case Report
- Keywords: Lentigo maligna; Melanoma; Toll-like receptor; Vitiligo
- MeSH: Aged; Biopsy; Burns; Cheek; Edema; Erythema; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle*; Inflammation; Lentigo*; MART-1 Antigen; Melanocytes; Melanoma*; Recurrence; Skin; Toll-Like Receptors; Vitiligo
- From:Annals of Dermatology 2018;30(4):454-457
- CountryRepublic of Korea
- Language:English
- Abstract: A 69-year-old man presented with a black irregular patch on his left cheek. Skin biopsy revealed lentigo maligna melanoma in situ. He was treated via partial excision of the melanoma, followed by the application of 5% imiquimod cream every other night for 6 to 8 hours. The patient experienced severe local inflammation accompanied by burning, edema, and erythema, as well as oozing and crusting. The patient discontinued using the imiquimod cream after 15 applications because of the inflammation. Depigmentation was noted in the treated area 3 months after the initiation of treatment with imiquimod cream. Histological examination using Melan-A staining of the depigmented area revealed an absence of melanocytes, which is consistent with vitiligo. The depigmented lesions improved considerably after a 5-year follow-up, and there was no recurrence of melanoma.
